Norbert Prenzel

Title: Norbert Prenzel: Innovator in Growth Factor Research

Introduction

Norbert Prenzel is a notable inventor based in Krailling, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of growth factors. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Norbert Prenzel holds a patent for "Heparin-binding epidermal growth factor-like growth factor binding proteins." This patent includes antigen binding proteins, such as human and/or monoclonal antibodies that have an affinity for heparin-binding epidermal growth factor-like growth factor (HB-EGF). These proteins are designed to neutralize the biological functions of this growth factor, highlighting Prenzel's focus on impactful medical innovations. He has 1 patent to his name.

Career Highlights

Throughout his career, Norbert Prenzel has worked with prominent companies in the biotechnology sector. He has been associated with U3 Pharma GmbH and Amgen Inc., where he has contributed to various research initiatives and product developments. His experience in these organizations has allowed him to refine his expertise and drive forward innovative projects.

Collaborations

Norbert has collaborated with several professionals in his field, including notable coworkers such as Mike Rothe and Eric Borges. These collaborations have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Norbert Prenzel's contributions to the field of growth factor research exemplify his commitment to innovation and medical advancement. His patent and collaborations reflect a career dedicated to improving therapeutic options in healthcare.